DICE Therapeutics Inc (DICE)
US23345J1043 - Common Stock
| MRQ (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 101.59M | 461.39M | 115.83M | 59.69M | 8.47M | |||
| Marketable Securities | 452.95M | 112.83M | 203.50M | 0.00 | 18.16M | |||
| Receivables | N/A | 0.00 | 2.00M | 2.00M | 2.00M | |||
| Other Current Assets | 4.80M | 3.54M | 2.59M | 364.00K | 466.00K | |||
| Total Current Assets | 559.35M | 577.76M | 323.91M | 62.05M | 29.09M | |||
| Non-Current Assets | ||||||||
| PPE Net | 16.06M | 16.02M | 1.65M | 1.66M | 1.93M | |||
| Other Non-Current Assets | 198.00K | 198.00K | 198.00K | 154.00K | 161.00K | |||
| Total Non-Current Assets | 16.25M | 16.22M | 1.84M | 1.81M | 2.09M | |||
| TOTAL ASSETS | 575.60M | 593.98M | 325.75M | 63.86M | 31.18M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 480.00K | 98.00K | 123.00K | |||
| Accrued Expenses | 13.12M | 12.07M | 8.69M | 2.98M | 1.72M | |||
| Accounts Payable | 4.12M | 3.08M | 1.71M | 5.09M | 1.01M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 1.13M | 863.00K | |||
| Total Current Liabilities | 17.24M | 15.15M | 10.88M | 9.29M | 3.71M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 1.92M | 0.00 | 99.00K | |||
| Other Non-Current Liabilities | 11.46M | 11.84M | 8.00K | 342.00K | 1.30M | |||
| Total Non-Current Liabilities | 11.46M | 11.84M | 1.92M | 342.00K | 1.40M | |||
| TOTAL LIABILITIES | 28.70M | 26.99M | 12.80M | 9.63M | 5.11M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -213.24M | -187.59M | -103.71M | -54.75M | -31.01M | |||
| Additional Paid In Capital | 760.44M | 755.17M | 416.71M | 1.60M | 1.38M | |||
| Common Shares | 5.00K | 5.00K | 4.00K | 107.37M | 55.69M | |||
| Other Shareholders' Equity | -297.00K | -597.00K | -58.00K | N/A | 10.00K | |||
| Shares Outstanding | 47.73M | 47.71M | 38.22M | 36.37M | 36.37M | |||
| Tangible Book Value per Share | 11.46 | 11.88 | 8.19 | -1.46 | -0.81 | |||
| Total Shareholders' Equity | 546.90M | 566.99M | 312.95M | 54.23M | 26.07M | |||
| TOTAL LIABILITIES AND EQUITY | 575.60M | 593.98M | 325.75M | 63.86M | 31.18M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.01 | N/A | 0.00 | |||
| Current Ratio | 32.44 | 38.14 | 29.77 | 6.68 | 7.85 | |||
| Return On Assets (ROA) | -15.80% | -14.12% | -15.03% | -37.17% | -41.49% | |||
| Return On Equity (ROE) | -16.63% | -14.80% | -15.64% | -43.78% | -49.63% | |||
All data in USD